Cryoprecipitated Antihemophilic Factor Market Forecast, Trend Analysis & Competition Tracking – Global Review 2018 to 2028
Status: Ongoing
Ask an Expert
Quick Pick
Cryoprecipitated Antihemophilic Factor is a portion of plasma rich in clotting factors including fibrinogen and factor VII. It is a dry, sterile and purified concentrate of antihemophilic factors like AHF and factor VII. Cryoprecipitated antihemophilic factor is prepared by freezing plasma and then slowly thawing the frozen plasma. It is used to control or prevent bleeding in the people with hemophilia and von Willebrands disease, which are the most commonly inherited coagulation disorders.

Source: Click here